These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 9657197

  • 1. Tamoxifen inhibits GH3 cell growth in culture via enhancement of apoptosis.
    Lee SY, Ahn BT, Baik SH, Lee BL.
    Neurosurgery; 1998 Jul; 43(1):116-23. PubMed ID: 9657197
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor, insulin, and estrogen stimulate development of prolactin-secreting cells in cultures of GH3 cells.
    Kakeya T, Takeuchi S, Takahashi S.
    Cell Tissue Res; 2000 Feb; 299(2):237-43. PubMed ID: 10741464
    [Abstract] [Full Text] [Related]

  • 3. Induction of mammotroph development by a combination of epidermal growth factor, insulin, and estradiol-17beta in rat pituitary tumor GH3 cells.
    Kakeya T, Takeuchi S, Takahashi S.
    Zoolog Sci; 2002 Jul; 19(7):789-95. PubMed ID: 12149580
    [Abstract] [Full Text] [Related]

  • 4. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats.
    Spritzer PM, Ribeiro MF, Oliveira MC, Barbosa-Coutinho LM, Silva IS, Dahlem N, Cericatto R, Pavanato MA.
    Horm Metab Res; 1996 Apr; 28(4):171-6. PubMed ID: 8740191
    [Abstract] [Full Text] [Related]

  • 5. Effects of bromocriptine on hormone production and cell growth in cultured rat pituitary cells.
    Johansen PW, Haug E, Gautvik KM.
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):200-6. PubMed ID: 4060970
    [Abstract] [Full Text] [Related]

  • 6. Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine.
    Li Q, Su Z, Liu J, Cai L, Lu J, Lin S, Xiong Z, Li W, Zheng W, Wu J, Zhuge Q, Wu Z.
    Mol Cell Endocrinol; 2014 Jan 25; 382(1):377-384. PubMed ID: 24184771
    [Abstract] [Full Text] [Related]

  • 7. Hormonal and morphologic effects of bromocriptine on normal rat pituitary and GH3 tumor cells.
    Lahteenmaki P, Marrs RP, Schechter J, Zacharias S, Kletzky OA.
    Am J Obstet Gynecol; 1985 Oct 15; 153(4):349-57. PubMed ID: 4050909
    [Abstract] [Full Text] [Related]

  • 8. Effects of bromocriptine and terguride on cell proliferation and apoptosis in the estrogen-stimulated anterior pituitary gland of the rat.
    Yonezawa K, Tamaki N, Kokunai T.
    Neurol Med Chir (Tokyo); 1997 Dec 15; 37(12):901-6. PubMed ID: 9465588
    [Abstract] [Full Text] [Related]

  • 9. Effects of estradiol on prolactin and growth hormone messenger RNAs in cultured normal and neoplastic (MtT/W15 and GH3) rat pituitary cells.
    Song JY, Jin L, Lloyd RV.
    Cancer Res; 1989 Mar 01; 49(5):1247-53. PubMed ID: 2917354
    [Abstract] [Full Text] [Related]

  • 10. Effects of bromocriptine and tamoxifen on growth and hormone receptor levels of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Waseda N, Kato Y, Matsushita N, Imura H.
    Endocrinol Jpn; 1983 Aug 01; 30(4):529-35. PubMed ID: 6323151
    [Abstract] [Full Text] [Related]

  • 11. D2 dopamine-receptor-mediated inhibition of proliferation of rat lactotropes in culture is accompanied by changes in cell shape.
    Arita J, Hashi A, Hoshi K, Mazawa S, Suzuki S.
    Neuroendocrinology; 1998 Sep 01; 68(3):163-71. PubMed ID: 9734000
    [Abstract] [Full Text] [Related]

  • 12. Differences in the interaction between dopamine and estradiol on prolactin release by cultured normal and tumorous human pituitary cells.
    Lamberts SW, Verleun T, Hofland L, Oosterom R.
    J Clin Endocrinol Metab; 1986 Dec 01; 63(6):1342-7. PubMed ID: 3782422
    [Abstract] [Full Text] [Related]

  • 13. Differential actions of the dopamine agonist bromocriptine on growth of SMtTW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression.
    Trouillas J, Chevallier P, Remy C, Rajas F, Cohen R, Calle A, Hooghe-Peters EL, Rousset B.
    Endocrinology; 1999 Jan 01; 140(1):13-21. PubMed ID: 9886801
    [Abstract] [Full Text] [Related]

  • 14. Bromocriptine inhibits incorporation of [3H]thymidine into rat pituitary tumor cells.
    Melmed S, Fagin J, Leung M.
    Brain Res; 1986 Mar 26; 369(1-2):83-90. PubMed ID: 3697756
    [Abstract] [Full Text] [Related]

  • 15. Effects of bromocriptine on experimental GH3 cell tumors.
    Kamijo K, Sato M, Saito T, Yachi A, Minase T.
    Pathol Res Pract; 1991 Jun 26; 187(5):593-7. PubMed ID: 1923956
    [Abstract] [Full Text] [Related]

  • 16. Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions.
    Jaquet P, Gunz G, Grisoli F.
    Horm Res; 1985 Jun 26; 22(3):153-63. PubMed ID: 3932176
    [Abstract] [Full Text] [Related]

  • 17. Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors: in vitro culture studies.
    Eguchi K, Kawamoto K, Uozumi T, Ito A, Arita K, Kurisu K.
    Endocr J; 1995 Jun 26; 42(3):413-20. PubMed ID: 7670571
    [Abstract] [Full Text] [Related]

  • 18. Interactions of steroids with prolactin secretion in vitro.
    Lamberts SW.
    Horm Res; 1985 Jun 26; 22(3):172-8. PubMed ID: 4054837
    [Abstract] [Full Text] [Related]

  • 19. The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.
    Lamberts SW, de Quijada M, Klijn JG.
    J Endocrinol Invest; 1980 Jun 26; 3(4):343-7. PubMed ID: 7204884
    [Abstract] [Full Text] [Related]

  • 20. Effect of bromocriptine on cell apoptosis and proliferation in GH3 cell culture.
    Wasko R, Wolun-Cholewa M, Bolko P, Kotwicka M.
    Neuro Endocrinol Lett; 2004 Jun 26; 25(3):223-8. PubMed ID: 15349090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.